HR
IART icon

Howe & Rusling’s Integra LifeSciences IART Stock Holding History

Howe & Rusling’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-86
Closed -$4K – 649
2022
Q3 		$4K Buy
86
+13
+18% +$666 ﹤0.01% 717
2022
Q2 		$4K Buy
73
+3
+4% +$180 ﹤0.01% 698
2022
Q1 		$4K Hold
70
– – ﹤0.01% 720
2021
Q4 		$5K Buy
70
+3
+4% +$203 ﹤0.01% 672
2021
Q3 		$5K Buy
67
+18
+37% +$1.27K ﹤0.01% 647
2021
Q2 		$3K Sell
49
-11
-18% -$778 ﹤0.01% 745
2021
Q1 		$4K Sell
60
-15
-20% -$1.02K ﹤0.01% 676
2020
Q4 		$5K Sell
75
-16
-18% -$861 ﹤0.01% 610
2020
Q3 		$4K Buy
91
+26
+40% +$1.24K ﹤0.01% 597
2020
Q2 		$3K Buy
+65
New +$3.19K ﹤0.01% 610

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Howe & Rusling's IART Position: Q4 2022 in Review

Howe & Rusling sold out of Integra LifeSciences (IART) in Q4 2022, closing a stake of 86 shares — an estimated $4K sold.

Howe & Rusling first reported a position in IART in Q2 2020 and held it in 10 quarters. The position peaked at $5K in Q4 2021. 281 funds tracked by Wall St. Rank hold IART as of Q4 2022.

  • Howe & Rusling reported no remaining Integra LifeSciences position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 86 Integra LifeSciences shares in Q4 2022, an estimated $4K.
  • Howe & Rusling first reported a position in Integra LifeSciences in Q2 2020 and held it in 10 quarters.
  • Howe & Rusling's Integra LifeSciences position peaked at $5K in Q4 2021.
  • 281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.